Department of Inherited Metabolic Disorders, Shenzhen Children's Hospital, Shenzhen, China.
Department of Respiratory Diseases, Shenzhen Children's Hospital, Shenzhen, China.
Front Endocrinol (Lausanne). 2024 Mar 13;15:1345067. doi: 10.3389/fendo.2024.1345067. eCollection 2024.
Mandibuloacral dysplasia (MAD) syndrome is a rare genetic disease. Several progeroid syndromes including mandibuloacral dysplasia type A (MADA), mandibuloacral dysplasia type B(MADB), Hutchinson-Gilford progeria (HGPS) and mandibular hypoplasia, deafness, and lipodystrophy syndrome (MDPL) have been reported previously. A novel MAD progeroid syndrome (MADaM) has recently been reported. So far, 7 cases of MADaM diagnosed with molecular diagnostics have been reported in worldwide. In the Chinese population, cases of MAD associated with the variant have never been reported.
The clinical symptoms and the genetic analysis were identified and investigated in patients presented with the disease. In addition, we analyzed and compared 7 MADaM cases reported worldwide and summarized the progeroid syndromes reported in the Chinese population to date.
The present study reports a case of a novel homozygous mutation c.378 + 1G > A in the gene, which has not been previously reported in the literature. Patients present with early onset and severe symptoms and soon after birth are found to have growth retardation. In addition to the progeroid features, skeletal deformities, generalized lipodystrophy reported previously, and other multisystem involvement, e.g. hepatosplenic, renal, and cardiovascular system, this case was also reported to have combined hypogammaglobulinemia. She has since been admitted to the hospital several times for infections. Among 22 previously reported progeroid syndromes, 16/22 were MADA or HGPS caused by gene mutations, and the homozygous c.1579C > T (p.R527C) mutation may be a hot spot mutation for MAD in the Chinese population. MAD and HGPS mostly present in infancy with skin abnormalities or alopecia, MDPL mostly presents in school age with growth retardation as the first manifestation, and is often combined with an endocrine metabolism disorder after several decades.
This is the first case of MAD syndrome caused by mutations in gene reported in the Chinese population. gene c.378 + 1G > A homozygous mutation has not been previously reported and the report of this patient expands the spectrum of mutations. In addition, we summarized the genotypes and clinical characteristics of patients with progeroid syndromes in China.
先天性脂肪营养不良-骨发育不全综合征(MAD)是一种罕见的遗传性疾病。以前曾报道过几种早衰综合征,包括 A 型先天性脂肪营养不良-骨发育不全(MADA)、B 型先天性脂肪营养不良-骨发育不全(MADB)、Hutchinson-Gilford 早衰症(HGPS)和下颌骨发育不全、耳聋和脂肪营养不良综合征(MDPL)。最近报道了一种新的 MAD 早衰综合征(MADaM)。迄今为止,已在全球范围内报道了 7 例通过分子诊断确诊的 MADaM 病例。在中国人群中,从未报道过与该变异相关的 MAD 病例。
对就诊的患者进行临床症状和基因分析。此外,我们分析并比较了全球报道的 7 例 MADaM 病例,并总结了迄今为止在中国人群中报道的早衰综合征。
本研究报告了一例新型纯合突变 c.378 + 1G > A 在 基因中,该突变以前未在文献中报道过。患者出生后即出现早发、严重症状,出生后不久即出现生长迟缓。除了以前报道的早衰特征、骨骼畸形、全身性脂肪营养不良和其他多系统受累,如肝脾、肾脏和心血管系统外,该病例还伴有联合低丙种球蛋白血症。此后,她因感染多次住院。在以前报道的 22 种早衰综合征中,16/22 是由 基因突变引起的 MADA 或 HGPS,纯合 c.1579C > T(p.R527C)突变可能是中国人群中 MAD 的热点突变。MAD 和 HGPS 主要在婴儿期出现皮肤异常或脱发,MDPL 主要在学龄期以生长迟缓为首发表现,几十年后常合并内分泌代谢紊乱。
这是首例在中国人群中报道的由 基因突变引起的 MAD 综合征。 基因 c.378 + 1G > A 纯合突变以前未被报道过,该患者的报告扩展了 突变谱。此外,我们总结了中国早衰综合征患者的基因型和临床特征。